Bronnen:
- Panaccione R, Colombel JF, Travis SPL, et al. Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial. Gut. 2019 Jul 8.
Bronnen:
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties
nov 2023 | Pancreatitis
sep 2023 | IBD
nov 2021
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
dec 2020 | IBD
jan 2020 | Hepatologie
jul 2024
sep 2023